-
Signature
-
/s/ Ben Hohl, by power of attorney
-
Issuer symbol
-
ELVN
-
Transactions as of
-
18 Aug 2025
-
Net transactions value
-
-$30,343
-
Form type
-
4/A - Amendment
-
Filing time
-
21 Aug 2025, 18:48:30 UTC
-
Date Of Original Report
-
20 Aug 2025
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Kintz Samuel |
PRESIDENT AND CEO, Director |
C/O ENLIVEN THERAPEUTICS, INC., 6200 LOOKOUT ROAD, BOULDER |
/s/ Ben Hohl, by power of attorney |
21 Aug 2025 |
0001967168 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ELVN |
Common Stock |
Sale |
$30,343 |
-1,517 |
-0.16% |
$20.00 |
927,892 |
20 Aug 2025 |
See footnote |
F1, F2, F3, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: